Tools for travellers' diarrhoea: Bring back the vaccine?

Travel Medicine and Infectious Disease

Volumn 12, Issue 4, 2014, Pages 305-306

  Petersen, Eskild ^a   Rombo, Lars ^b,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; VACCINE; ANTIDIARRHEAL AGENT; LOPERAMIDE;

CHOLERA; EDITORIAL; ESCHERICHIA COLI; HUMAN; MILITARY DEPLOYMENT; NONHUMAN; PRIORITY JOURNAL; TRAVEL; TRAVELLER DIARRHEA; VIBRIO CHOLERAE; DIARRHEA; FEMALE; MALE; SOLDIER; STATISTICS AND NUMERICAL DATA;

ANTIDIARRHEALS; DIARRHEA; FEMALE; HUMANS; LOPERAMIDE; MALE; MILITARY PERSONNEL; TRAVEL;

EID: 84905584327     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2014.06.001     Document Type: Editorial

References (12)

1. A. Letizia, M.S. Riddle, D. Tribble, M. Mostafa, M. Monteville, and A. Armstrong et al. Effects of pre-deployment loperamide provision on use and travelers' diarrhea outcomes among U.S. military personnel deployed to Turkey Travel Med Infect Dis 12 4 2014 360 363
2. A.M. Svennerholm, J. Holmgren, R. Black, M. Levine, and M. Merson Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli J Infect Dis 147 1983 514 522
3. A.M. Svennerholm, and D. Steele Microbial-gut interactions in health and disease. Progress in enteric vaccine development Best Pract Res Clin Gastroenterol 18 2004 421 445
4. J.D. Clements, and R.A. Finkelstein Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin Infect Immun 21 3 1978 Sep 1036 1039
5. H. Peltola, A. Siitonen, H. Kyrönseppä, I. Simula, L. Mattila, and P. Oksanen et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine Lancet 338 1991 1285 1289
6. E.G. Scerpella, J.L. Sanchez, J.J. Mathewson III, J.V. Torres-Cordero, J.C. Sadoff, and A.M. Svennerholm et al. Safety, immunogenicity, and protective efficacy of the whole-cell/recombinant B subunit (WC/rBS) oral cholera vaccine against travelers' diarrhea J Travel Med 2 1995 22 27
7. E.S.1 Lestari, J.A. Severin, and H.A. Verbrugh Antimicrobial resistance among pathogenic bacteria in Southeast Asia Southeast Asian J Trop Med Public Health 43 2012 385 422
8. D.M. Livermore Fourteen years in resistance Int J Antimicrob Agents 39 2012 283 294
9. J.S. Molton, P.A. Tambyah, B.S. Ang, M.L. Ling, and D.A. Fisher The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia Clin Infect Dis 56 2013 1310 1318
10. http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Scientific- Discussion/human/000476/WC500037566.pdf.
11. R.H. Behrens, J.P. Cramer, T. Jelinek, H. Shaw, F. von Sonnenburg, and D. Wilbraham et al. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala Lancet Infect Dis 14 2014 197 204
12. R.H. Behrens, and J.A. Roberts Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers BMJ 309 1994 918 922